Healthcare provider profile · identity verified

Richard Ogunti, MD

Internal Medicine · MANKATO, MN · NPI 1992236046

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	214	70
Levothyroxine Sodium	Levothyroxine Sodium	213	65
Rosuvastatin Calcium	Rosuvastatin Calcium	172	44
Amlodipine Besylate	Amlodipine Besylate	162	54
Metoprolol Succinate	Metoprolol Succinate	161	41
Lisinopril	Lisinopril	158	38
Losartan Potassium	Losartan Potassium	158	53
Pantoprazole Sodium	Pantoprazole Sodium	158	41
Gabapentin	Gabapentin	141	36
Furosemide	Furosemide	100	35
Omeprazole	Omeprazole	98	33
Potassium Chloride	Potassium Chloride	93	25
Sertraline Hcl	Sertraline Hcl	90	25
Metoprolol Tartrate	Metoprolol Tartrate	80	26
Metformin Hcl Er	Metformin Hcl	78	23
Warfarin Sodium	Warfarin Sodium	71	18
Ozempic	Semaglutide	70	17
Tramadol Hcl	Tramadol Hcl	65	21
Fluticasone Propionate	Fluticasone Propionate	64	27
Pravastatin Sodium	Pravastatin Sodium	62	17
Tamsulosin Hcl	Tamsulosin Hcl	58	19
Simvastatin	Simvastatin	57	18
Oxycodone Hcl	Oxycodone Hcl	56	20
Carvedilol	Carvedilol	54	17
Famotidine	Famotidine	52	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	14
Eliquis	Apixaban	50	12
Jardiance	Empagliflozin	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	11
Celecoxib	Celecoxib	47	17
Trazodone Hcl	Trazodone Hcl	47	16
Montelukast Sodium	Montelukast Sodium	46	suppressed
Metformin Hcl	Metformin Hcl	45	20
Alendronate Sodium	Alendronate Sodium	38	11
Glimepiride	Glimepiride	38	14
Prednisone	Prednisone	38	22
Spironolactone	Spironolactone	37	16
Donepezil Hcl	Donepezil Hcl	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Lorazepam	Lorazepam	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Torsemide	Torsemide	34	12
Hydralazine Hcl	Hydralazine Hcl	31	12
Cephalexin	Cephalexin	28	17
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	27	12
Albuterol Sulfate Hfa	Albuterol Sulfate	25	19
Mupirocin	Mupirocin	23	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	22	13
Topiramate	Topiramate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	13
Baclofen	Baclofen	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Finasteride	Finasteride	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	16	16
Latanoprost	Latanoprost	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Metolazone	Metolazone	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valsartan	Valsartan	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Linzess	Linaclotide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error